Unit 1 Flashcards

1
Q

Name two ways drugs are excreted from the body

A

Excretion (drug eliminated intact)

Biotransformation (elimination of metabolite)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the possible results of biotransformation of a drug?

A

Inactive metabolites
Active metabolites
Toxic metabolites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What (generally) is Phase I Biotransformation?

A

Change in structure of a drug to form more polar metabolites, which can be active, toxic, or inactive.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is (generally) Phase II Biotransformation?

A

Conjugation of endogenous structure to a drug to form a larger, polar, almost always inactive metabolites.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What (specifically) is Phase I Biotransformation?

A

Reduction
Oxidation
Hydrolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What (specifically) is Phase II Biotransformation?

A
Glucuronidation
Acetylation
Methylation
Sulfation
Conjugation to amino acid (glycine)
Conjugation to glutathione
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why are drugs metabolized differently by different species?

A

Variations in the types of CYP enzymes (cytochrome p450) that the animal expresses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Where does drug biotransformation occur? (6 sites)

A
LIVER
Plasma/Blood
Kidney
Lung
Intestinal mucosa
GI flora
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is a first order process?

A

When drug ADME increases proportionally with drug concentration (linear process on a log scale graph).
Seen before a biological system (transporter, enzyme) is saturated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is a zero order process?

A

When drug ADME does not increase proportionally with drug concentration (non-linear process on a log scale graph).
Seen after a biological system (transporter, enzyme) is saturated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Name two differences that could result in differing drug metabolism between species or groups.

A
Enzyme structures (mutations, etc) 
Enzyme availability at site of biotransformation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why is acetaminophen dangerous for cats?

A

Slow rate of acetaminophen glucuronidation = greater saturation of enzymes = greater plasma drug concentrations = methemoglobinemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why is piroxicam longer lasting in dogs than in cats?

A

Cats oxidize drug more quickly than dogs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why do dogs eliminated sulfonamide antibiotics by alternative routes?

A

They lack N-acetyl transferase.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why do cats have low elimination rates of sulfa drugs?

A

They lack N-acetyl transferase 2 and so have lower acetylation rates.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why does azathioprine lead to myelotoxicity in cats?

A

They have low thiopurine methyltransferase activity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What group exhibits slow propofol elimination?

A

Greyhounds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What group exhibits neurotoxicity with ivermectin?

A

White feet don’t treat

MDR-1 mutants, often seen in collies, aussies, long-haired whippets, border collies, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is enzyme induction?

A

When a drug increases the rate of transformation of another drug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is enzyme inhibition?

A

When another drug or a systemic process decreases the rate of transformation of a drug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is first pass loss?

A

Biotransformation of the drug before it reaches systemic circulation. Mainly from the liver but also can be seen in GI tract, with flora, through kidneys in some species, etc. Also will be affected by induction or inhibition of biotransformation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What reaction do CYP enzymes facilitate?

A

Microsomal oxidation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What transport mechanism is severely inhibited by chemotherapeutic drugs?

A

P-glycoprotein mediated excretion of conjugated drugs into the biliary system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are the three processes of excretion in the kidney and which is the most important?

A

SECRETION
Filtration
Reabsorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What type of molecules are secreted by the kidney?

A

small, polar, unbound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What type of molecules are filtered by the kidney?

A

small, polar, unbound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What type of molecules are reabsorbed by the kidney?

A

small, non-polar, unbound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What are the body’s routes of excretion? (6)

A
Renal
Gastrointestinal (biliary)
Pulmonary
Mammary
Sweat
Saliva
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Does milk trap acids or bases?

A

Bases. Milk has a significantly lower pH than plasma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

To produce a pharmacological effect, what three things must a drug be in the body?

A

Present at site of action
At a sufficient concentration
For a specific period of time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What does a pharmacokinetic study of a drug entail? (4)

A

Drug administration route
Blood sampling over set periods of time
Determination of drug concentration in each sample
PK analysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What is a pharmacokinetic parameter?

A

A mathematical model of drug in the body over time.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What are the dose dependent PK parameters?

A

Cmax

AUC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What are the dose independent PK parameters?

A
Tmax
Bioavailability 
Clearance
Volume of drug distribution (Vd)
Half-life
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What does Cmax represent?

A

Maximal concentration of the drug in the plasma, directly proportional to dose. With a larger Cmax, should see a larger intensity of pharmacological effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What does AUC represent?

A

Area under the curve - reflects exposure to drug and duration of drug. Will also be affected by formulation and route of drug administration.
Directly proportional to dose and bioavailability.
Inversely proportional to drug clearance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

By increasing the dose of a drug, what will you see in the patient?

A

Increased intensity, duration, and exposure to the drug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What does Tmax represent?

A

Time to Cmax. May be close to time of drug onset, but not always.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

How much drug will be eliminated after 5 half lives?

A

97%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

How much drug will be eliminated after 10 half lives?

A

99.9% - effectively all, drug considered to be gone from the body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

How can drug bioavailability be used to calculate extravascular doses?

A

EV dose = IV dose / F

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

What is F defined as?

A

Bioavailability: the rate and extent of drug absorption after extravascular drug administration.
F = AUC EV / AUC IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Name some factors that will affect F.

A
Liver disease 
Concurrent drugs acting as liver enzyme inducers/inhibitors
Compounded formulations
GI disease (oral administration) 
Dehydration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

What is the formal definition of clearance?

A

The rate of drug elimination scaled by plasma drug concentration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

What is the operational definition of clearance?

A

The volume of plasma cleared of drug per unit time.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

What is Vd?

A

Volume of distribution - reflects the dilution of drug in the body. Value is proportional to the amount of drug in the target tissue vs amount of drug in the blood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

What are the consequences of a low Vd?

A

Most of drug in blood rather than target tissue, leading to slow or limited intensity of effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

What are the consequences of a high Vd?

A

Most of drug in target tissue rather than blood, faster or greater intensity of effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

What may cause a low Vd?

A

Extensive binding of drug to plasma proteins

Physical barrier that does not allow much drug passage (like blood brain barrier)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

What may cause a high Vd?

A

High numbers of binding sites in tissues
Lipid soluble
Ion trapped in non-plasma compartments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Is a drug with a low or high Vd more likely to be reabsorbed by the kidney?

A

High Vd. Low Vd is likely to be protein bound and so not filtered in the first place. High Vd is more likely to be lipid soluble and so passively is reabsorbed from the renal tubules due to concentration gradient.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

What physiologic conditions can affect Vd and how? (4)

A

Pregnancy - increase Vd of water soluble drugs
Neonatal animals - increase Vd due to lower extent of plasma protein drug binding
Ruminants - increase Vd of water soluble drugs
Excitement/Exercise - increase Vd by increasing blood flow to organs and thus speeding up distribution.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

What pathologic conditions can affect Vd and how? (3)

A

Shock - decrease Vd by slowing blood flow to organs and thus slowing distribution.
Obesity - increase Vd of fat soluble drugs
Ascites - increase Vd of water soluble drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

What is t1/2?

A

Drug half life: the time it takes to decrease the plasma drug concentration by one half.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Give the equation to calculate half-life

A

T1/2 = (0.693 x Vd) / CL
Directly proportional to Vd (more drug in plasma, faster elimination)
Inversely proportional to clearance (less drug being cleared, longer life of drug in plasma).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

What is the therapeutic window?

A

The dose range between the maximum tolerated drug concentration and minimum effective drug concentration. In this range the drug should be both safe and effective.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

What is the MOS?

A

The size of the therapeutic window (maximum tolerated drug concentration - minimum effective drug concentration).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

What does a non-linear PK mean clinically?

A

You cannot predict how fast the plasma drug concentration will increase or decrease in the body, or exactly what final plasma concentration will be reached.
It doesn’t mean you CAN’T safely increase the dose, but you just don’t know.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

When can you increase the dosage of a drug safely in a patient?

A

When the MOS is large and the drug has LK.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

When is it unsafe to increase the dosage of a drug in a patient?

A

When the MOS is small or the drug has NLK.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

When might you consider a CRI clinically?

A

When half life of drug is very short

When drug is dangerous (so you can avoid peaks in Cp)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

How long does it take you to reach Cplat when giving a CRI?

A

5HL (only 97% technically, but functionally this is going to work well)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

What should your CRI loading bolus be?

A

Double the desired Cplat for one half life of the drug, then reduced.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

What is the danger of a loading dose?

A

If adverse reactions are seen with the drug, there is no way to stop the drug before Cplat is reached, so it will take longer for drug amount to be eliminated to safe amounts in the body (i.e. if drug started causing harmful side effects at 0.5 Cplat it will take one more half life for drug to be eliminated to non-toxic doses)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

How long does it take to reach a new Cplat when adjusting the rate of a CRI?

A

5HL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

What is infusion rate?

A

Amount of drug per unit time given in a CRI (mg/ml)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

What is flow rate?

A

Volume of solution per unit time given in a CRI.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

What is the physiological meaning of the Cplat?

A

A point at which rate of infusion = rate of elimination.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

With intermittent dosing, what is Cp max?

A

Maximal concentration of drug reached after first administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

With intermittent dosing, what are Css min and Css max?

A

Concentrations of drugs reached at plateau / steady state.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

With intermittent dosing, what is Css ave proportional too?

A

Directly proportional to dose.

Inversely proportional to dose interval.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

When will a drug accumulate in the body during intermittent dosing?

A

When the dosing interval is less than 3 half lives.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

With intermittent dosing, what is the RDI and what does it mean?

A

Relative Dosing Interval

Predicts the rate of drug accumulation in the body due to drug half life and dosing interval.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

What is the mathematical formula for RDI?

A

RDI = DI / HL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

Predict the rate of drug accumulation with a small RDI.

A

Fast (especially if fractional)

76
Q

Predict the rate of drug accumulation with a large RDI.

A

Slow (or none if greater than 3)

77
Q

What does the Accumulation Factor (FAC) represent?

A

Inverse of the fraction of drug lost during the dosage interval.

78
Q

What is the relationship between the RDI and the FAC?

A

Inversely proportional.

79
Q

How do you calculate a loading dose with intermittent dosing?

A

Loading dose = maintenance dose x FAC

80
Q

How many doses does it take to reach steady state with intermittent dosing?

A

5HL / dosing interval

81
Q

How is RDI related to fluctuation?

A

Css max / Css min = 2 RDI

82
Q

How can amount of fluctuation be reduced with intermittent dosing?

A

Smaller doses of drug more at smaller dosing intervals.

83
Q

Define pharmacology.

A

The study of how drugs are handled by the body and why they produce an effect.

84
Q

Define pharmacy.

A

The study of dispensing or delivering drugs to a patient.

85
Q

Define toxicology.

A

The study of undesired effects of an agent on the body.

86
Q

Explain the difference between a targeted and non-targeted drug mechanism.

A

Most drugs bind to a specific target, either activating or inactivating that target. This allows for drugs to be selective in their effects. Non-targeted drugs change the environment instead - change pH, ion concentration, osmolarity, etc. These drugs include salves, chelators, and antacids and have no specific targets.

87
Q

Name the five most common examples of drug targets.

A
Receptors 
Ion channels
Enzymes
Nucleic acids (DNA/RNA)
Membrane transport proteins
88
Q

What determines the speed of onset of a drug?

A

Pharmacokinetics

Type of receptor the drug binds (pharmacodynamics)

89
Q

What is a receptors normal role?

A

Monitor and respond to cell external environment.

90
Q

Name four categories of receptors and how fast each can respond to stimulation

A

Ligand gated ion channels (msec)
G-coupled protein receptors (sec to mins)
Receptor regulated enzymes (mins to hours)
Intracellular receptors (hours to days)

91
Q

Name one example of a receptor in each class.

A

Ligand gated: Nicotinic acetylcholine receptor, glutamate or GABA receptors, serotonin receptors.
GPCR: Muscarinic acetylcholine receptor, histamine receptors, opioid receptors.
Receptor-regulated enzymes: Tyrosine kinase receptors for insulin or growth factors, guanylyl cyclase.
Intracellular: Steroid receptors, thyroid hormone receptor, Vitamin D receptor.

92
Q

Name one drug example for a receptor in each class.

A

Ligand gated: Ketamine
GPCR: Epinephrine, opioids
Receptor regulated: Insulin
Intracellular: Corticosteroids

93
Q

Name one drug example that binds a non-ligand gated ion-channel.

A

Lidocaine (and other local anesthetics) - binds and inhibits voltage-gated Na+ channels.

94
Q

Name one drug example that binds an enzyme.

A

NSAIDs (Inhibit COX enzymes)

95
Q

Name three ways that drugs that bind enzymes may work to produce an effect.

A

Inhibit production of transmitter/hormone - onset of action as endogenous protein breaks down.
Inhibit breakdown of transmitter/hormone - onset of action is as more endogenous protein is created.
Inhibiting intracellular enzymes to change cell signaling pathways.

96
Q

Name one drug that binds a membrane transport protein.

A

SSRI - prevents the reuptake of serotonin by presynaptic neurons.

97
Q

Name one drug that binds DNA or RNA.

A

Antineoplastics (doxorubicin) and antivirals (pyrimidine nucleoside analogs)

98
Q

Name some examples of non-targeted drugs

A
Chelators
Salves
Pore-forming antibiotics
Antacids
IV fluids (electrolytes) 
Osmotic agents (mannitol)
99
Q

Name a drug with an unknown mechanism

A

Anesthetic agents (isoflurane, propofol). Not known if these are targeted or non-targeted. Act at least in part by binding to glycine and GABA receptors, but more is going on.

100
Q

What does a drug do when it binds to a receptor?

A

Stabilizes either the active (signaling) state or inactive (non-signaling) state.

101
Q

What is drug affinity?

A

The ability of a drug to bind a receptor.

102
Q

What is drug efficacy?

A

The ability of a drug to produce a response.

103
Q

Name three types of efficacy

A
Receptor efficacy (molecular)
Cellular efficacy 
Clinical efficacy (response in whole animal)
104
Q

What is an agonist?

A

Ligand that activates a receptor. Can be full or partial.

105
Q

What is an antagonist?

A

Ligand that stabilizes inactive state of a receptor.

106
Q

What determines the efficacy of an antagonist?

A

Concentration/tone of the endogenous agonist that the antagonist is blocking.

107
Q

What does Kd define?

A

The concentration of a drug required to occupy 50% of receptors at equilibrium.

108
Q

What is the relationship between Kd and affinity?

A

Inversely proportional.

109
Q

What is the relationship between Kd and receptor efficacy?

A

There is none. Kd tells us that a drug can bind, but does not tell us if it produces an effect.

110
Q

How do you measure cellular efficacy of a drug?

A

A biological assay - example given is piece of ileum in a physiological bath that includes drug, where force of contraction of the tissue is measured.

111
Q

What type of graph is created while measuring cellular efficacy?

A

Dose-response curve.

112
Q

What is the EC50?

A

The concentration of drug required to produce 50% of the maximal effect of the drug.

113
Q

How is EC50 related to efficacy?

A

Inversely proportional.

114
Q

How is EC50 related to affinity?

A

It is not related. Drugs with low affinity for receptors can still be efficacious.

115
Q

How do Kd and EC50 compare for an agonist at a clinical or cellular level? What is the name of this effect?

A

Kd > EC50
This indicates the presence of SPARE RECEPTORS - a large effect is being produced with only a small percent of receptors bound.

116
Q

How do Kd and EC50 compare for an antagonist at a clinical or cellular level? What is the name of this effect?

A

Kd < EC50
This indicates a THRESHOLD EFFECT - a smaller effect is being produced with a large percentage of receptors bound - generally antagonists must bind a large percentage of receptors in order to block endogenous agonist (consider the endogenous agonist to usually have a spare receptor effect).

117
Q

How do EC50 and Kd relate at the molecular level?

A

Generally at a molecular level, Kd50 and EC50 are very well correlated.

118
Q

What does potency mean?

A

The concentration of a drug needed to produce a CLINICAL effect. Highly potent drugs require only a small concentration of drug to be effective.

119
Q

How do low potency drugs relate to high potency drugs in terms of ability to produce a clinical effect?

A

They both can create the same effect, but the low potency drug will need to be at a higher concentration.

120
Q

How might a high affinity drug have a low potency?

A

Drug has low efficacy
Drug does not gain access to site of action
Drug is rapidly metabolized or excreted.

121
Q

Relate stereoisomers to drug affinity.

A

Different stereoisomers of the same drug have different binding affinities, as receptors are proteins which have chiral amino acids.

122
Q

Name the four most common forces involved in drug-receptor binding from strongest to weakest.

A

Ionic interactions
Hydrogen bonds
Hydrophobic interactions
Van der Waal’s forces

123
Q

Most drugs bind (BLANK) with (BLANK) interactions.

A

Reversibly

Non-covalent

124
Q

Name one notable drug that binds irreversibly

A

Aspirin - forms a covalent interaction with cyclooxygenase.

125
Q

Name one advantage of high potency drugs

A

Only need a small volume (good for darts or if drug is expensive)

126
Q

Name one disadvantage of high potency drugs

A

Easy to overdose.

127
Q

How is a partial agonist defined?

A

Produces only partial activation of receptors even if high proportion of receptors are bound.

128
Q

What determines the effect of an agonist?

A

The ABSOLUTE NUMBER of receptors bound.

129
Q

Name and define the three classes of antagonists.

A

Pharmacological antagonists - bind to the same receptors as agonists and stabilizes their inactive state.
Physiological antagonists - oppose action of agonist by binding another receptor that activates an opposing signaling pathway. This may be on the same cell or in an entirely different system.
Pharmacokinetic antagonists - Removes the agonist from the system by binding to the agonist directly or reducing the absorption of the agonist.

130
Q

What are the two types of interactions that pharmacological antagonists can have with agonists?

A

Simple competitive interactions: Binds reversibly at the same site of the agonist - can be overwhelmed by high concentrations of the agonist so generally must be used at high concentrations.
Noncompetitive interactions: Either binds irreversibly at the same site as the agonist or binds at another site that prevents receptor activation even if the agonist is bound. Can be used at lower concentrations.

131
Q

Which class of antagonists is the safest?

A

Pharmacological antagonists - these have the most predictable effects.

132
Q

What is an inverse agonist?

A

Ligand that binds to a receptor that is NORMALLY in a signaling state and causes inactivation of that receptor. Relatively rare.

133
Q

Why does an anti-histamine do nothing if you are not having an allergic reaction?

A

Basal histamine tone (concentration) is very low. Anti-histamines are antagonists of histamine receptors, and if they block histamine receptors when there is no histamine present there is no observed clinical effect.

134
Q

What is a Quantal Dose-Response Curve?

A

A cumulative frequency curve that allows for comparison between individual responses in a population of animals.

135
Q

What is a therapeutic index?

A

An ARBITRARY ratio between dose that is effective for some percentage of the population and dose that is toxic or lethal to some percentage of the population.

136
Q

What is a safety factor?

A

Same as therapeutic index.

137
Q

What is ED50?

A

Dose that is effective for 50% of the population.

138
Q

What is TD50?

A

Dose that is toxic for 50% of the population.

139
Q

What is LD50?

A

Dose that is lethal for 50% of the population.

140
Q

How is therapeutic index calculated?

A

BAD % / Good %
So, LD50 / ED50
Or, TD3 / ED97
Or any combination of bad/good

141
Q

What are some major problems with using the therapeutic index as a reference?

A

Often the % values used are not defined
Varies greatly between species
What severity of problem is considered “toxic?”
What type of therapeutic effect is considered “effective?”
How steep is the quantal curve for toxicity?
Are the effects of chronic toxicity accounted for or only acute toxicities?

142
Q

What are two better measures of drug safety?

A

LOAEL: lowest observed adverse effect level
NOAEL: (greatest) no observed adverse effect level

143
Q

What are the two types of adverse reactions?

A

Type 1/A: Dose-related, predictable toxicity. Will occur in all individuals with high enough dose.
Type 2/B: Idiosyncratic toxicity, due to some abnormality of the individual - often allergic.

144
Q

What are the causes of Type 1 toxicity?

A

Over activation of normal target
Activation of lower-affinity non-target receptors at higher dose
Cytotoxicity/organ toxicity
Pharmacogenetics - when an individual has some sensitivity to a drug but effects are still dose related (white feet and ivermectin)

145
Q

What are the causes of Type 2 toxicity (types of immune reactions)?

A

Type I - anaphylaxis due to release of histamine. Requires previous exposure.
Type II - cytolysis due to formation of antigens on cells
Type III - creation of immune complexes
Type IV - delayed hypersensitivity/cell-mediated

146
Q

Define pharmacokinetics

A

The study of the time course of a drug in the body.

147
Q

Name the four physiologic processes that pharmacokinetics examines

A

Absorption
Distribution
Metabolism
Excretion

148
Q

What are the two phases of absorption?

A

Introduction of the drug into the body

Movement across several semipermeable membranes into systemic circulation (if IV, no absorption necessary)

149
Q

What 5 factors affect drug absorption?

A

Route of drug administration
Availability of drug at site of absorption
Local blood flow to site of administration
Physical barriers
Drug physicochemical properties

150
Q

Name 3 ways a drug can pass through the endothelium

A

Transcellular (passive diffusion through membrane)
Paracellular (between cells)
Facilitated transport

151
Q

When is drug influx rate by transporters directly proportional to drug concentration?

A

When transporters are not yet saturated.

152
Q

What are the physicochemical properties of a drug that is rapidly absorbed?

A

Lipid soluble (non-polar)
Small (low molecular weight)
Non-ionized

153
Q

What is the general mechanism of ion trapping?

A

Only uncharged molecules can pass through lipid membranes.
If a basic molecule passes into an acidic environment, it will become ionized and thus be trapped in tissues, and the same will happen with an acid in a basic environment.
Remember, acids and bases are at an ionized/non-ionized equilibrium, so may not trap all drug but will trap some.

154
Q

What are the advantages and disadvantages of oral drug administration?

A

A: easy
D: slow

155
Q

What are the advantages and disadvantages of topical drug administration?

A

A: easy, non-invasive
D: May cause unwanted effects if animal licks or damaged skin allows systemic access

156
Q

What are the advantages and disadvantages of mucosal drug administration?

A

A: Fast, good for local effects
D: May gain access to systemic circulation

157
Q

What are the advantages and disadvantages of parenteral (IV, IM, SQ, IP) drug administration?

A

A: Fast
D: May cause local tissue damage, harder to administer

158
Q

What are the advantages and disadvantages of aerosol drug administration?

A

A: VERY fast
D: Airway irritation

159
Q

What variables affect enteric drug absorption time?

A

Presence of food in stomach
pH of stomach/intestines
Intestinal flora loads
Gastric/intestinal transit time
Potential drug interactions/precipitation of drug
First pass effect
Formulation (must be in aqueous solution to be absorbed)

160
Q

What are the various oral drug formulations?

A
Tablets
Capsules 
Aqueous solution
Aqueous suspension (particles settle) 
Carriers
Implants
161
Q

What is distribution?

A

The reversible process of drug moving out of blood into the tissues. Again must pass through endothelium.

162
Q

What four factors does drug distribution influence?

A

Onset of action
Intensity of effect
Extent of effect
Adverse reaction

163
Q

What four factors influence drug distribution?

A

Blood flow to organs
Tissue barriers (ie BBB)
Drug physicochemical properties
Plasma protein binding

164
Q

What is the difference between a physical and functional barrier?

A

Physical - drug cannot pass due to physicochemical properties
Functional - drug can pass through membrane but is rapidly excreted by efflux transporters.

165
Q

Which tissues have greatest blood flow (and thus most rapid absorption/distribution)?

A
CNS
Liver
Lung
Gut
Kidney
Heart
Exercising muscle
166
Q

Which tissues have least blood flow (and thus least rapid absorption/distribution)?

A

Skin
Fat
Bone
Resting muscle

167
Q

When is a drug considered highly bound in the plasma?

A

If >80% drug is protein bound at equilibrium.

168
Q

Name the 7 physiologic/pathogenic conditions that affect distribution.

A
Ascites
Shock
Obesity
Pregnancy
Excitement/Exercise
Ruminants
Neonates
169
Q

Define tolerance.

A

Repeated administration of the same dose of drug fails to produce the same magnitude of response.

170
Q

What are the three general mechanisms for tolerance?

A

Pharmacokinetic
Pharmacodynamic
Physiologic

171
Q

What is pharmacokinetic tolerance?

A

The change in the metabolism rate of a drug, usually by the drug inducing liver enzyme functions.

172
Q

What is pharmacodynamic tolerance?

A

Change in receptor number or desensitization (conformation change) of a receptor.

173
Q

What is physiologic tolerance?

A

Loss/exhaustion of an endogenous mediator the drug releases or physiological adaptations of another system to compensate for changes due to drug.

174
Q

Why is it dangerous to stop beta adrenergic antagonists quickly?

A

The antagonist causes pharmacodynamic tolerance of the drug by increase in production of receptors so that the endogenous agonist is able to produce a large enough absolute number of bound receptors to produce an effect. Then if the drug is withdrawn the endogenous agonist produces a huge effect which can be dangerous.

175
Q

How can cross-tolerance be produced?

A

Can see cross-tolerance when drugs have very similar mechanisms of action or drugs act on the same receptor.

176
Q

What is tachyphylaxis?

A

Aka desensitization. The very rapid onset of (and very rapid recovery from) tolerance.

177
Q

What is refractoriness?

A

A loss of drug therapeutic effectiveness.

178
Q

What is drug resistance?

A

Generally used with microbial resistance.

179
Q

What is sensitization?

A

The opposite of tolerance - when repeated administration of a drug produces increased effects. Thought to be important with drug abuse.

180
Q

What are the three major mechanisms of drug-drug interactions?

A

Pharmacodynamic: Drugs act at the same receptor.
Physiologic: One drug changes target receptor expression of another drug or changes physiologic parameters like osmolarity in the body that changes the action of another drug.
Pharmacodynamic: one drug changes the ADME of another drug.

181
Q

What will be the pharmacodynamic action of two agonists?

A

Generally will not see any change in effect, especially as cross tolerance is prone to develop.

182
Q

What will be the pharmacodynamic action of an agonist and an antagonist?

A

Generally the agonist will be ineffective, though some change might be seen at high concentrations if the antagonist is competitive rather noncompetitive.

183
Q

What will be the pharmacodynamic action of two antagonists?

A

Generally will not see any change in effect (remember that antagonists already must be present at a very large percentage of receptors to be effective).

184
Q

How can pharmacokinetic drug-drug interactions change absorption? Give one example.

A

They can change the amount of drug available to be absorbed (GI chelators or activated charcoal) or alter the pH state of the drug (antacids in GI)

185
Q

How can pharmacokinetic drug-drug interactions change distribution? Give one example.

A

They can competitively displace drug from plasma or tissue proteins (aspirin and thyroxine) or cause increased sequestration in tissues (diuretics and ahminoglycosides causing ototoxicity).

186
Q

How can pharmacokinetic drug-drug interactions change metabolism? Give one example.

A

Induction or inhibition of metabolic enzymes. Important example: Phenobarbital inducing enzyme for itself and for warfarin/cortisone.

187
Q

How can pharmacokinetic drug-drug interactions change excretion? Give one example.

A

Generally, see changes in renal excretion. Seen with agents that alter urine pH (NaCHO3) or diuretics.